Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection
Open Access
- 15 March 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 221 (Supplement), 86-93
- https://doi.org/10.1093/infdis/jiz402
Abstract
Background. Several cytomegalovirus (CMV) vaccine candidates are under development. To reduce the burden of congenital CMV infection, potential strategies under consideration include vaccination of adult women, adolescent girls, and/or young children (both sexes). Methods. We reviewed 5 studies that used infectious disease modeling to assess the potential impact of vaccination for preventing congenital CMV infection. All models assumed CMV vaccination would prevent primary infection and 2 models also assumed prevention of reinfections and reactivations. Results. Despite differences in structure, assumptions, and population data, infant vaccination (both sexes) was the optimal strategy in all models, but in 1 model vaccinating seronegative women at 19-21 years of age was also optimal (for duration of vaccine protection >= 8 years). In 3 models, infant vaccination increased average age at primary infection as a result of decreased secondary transmission (herd immunity) combined with waning vaccine-induced immunity. This effect could increase the risk of congenital CMV infections in populations where primary CMV infection occurs early in childhood but could be minimized by administering a second dose of vaccine during adolescence. Conclusions. Understanding vaccine efficacy and duration of immunity, and how these might vary depending on CMV serostatus and age at vaccination, will be key to defining CMV vaccination strategies.Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institute of Child Health and Human Development
This publication has 32 references indexed in Scilit:
- Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected WomenThe Journal of Infectious Diseases, 2011
- The ABC of terms used in mathematical models of infectious diseasesJournal of Epidemiology and Community Health, 2010
- The construction of next-generation matrices for compartmental epidemic modelsJournal of The Royal Society Interface, 2009
- Vaccine Prevention of Maternal Cytomegalovirus InfectionThe New England Journal of Medicine, 2009
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious DiseasesPLoS Medicine, 2008
- Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infectionReviews in Medical Virology, 2007
- Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory CommitteeClinical Infectious Diseases, 2004
- Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlersThe Pediatric Infectious Disease Journal, 2002
- Encouraging prospects for immunisation against primary cytomegalovirus infectionVaccine, 2001
- Cytomegalovirus seroepidemiology in an urban community of São Paulo, BrazilRevista de Saúde Pública, 2001